NAGE FY 2022 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$423M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$72M+6.8% YoY

Gross Profit

$43M59.4% margin

Operating Income

-$19M-25.9% margin

Net Income

-$17M-23.0% margin

EPS (Diluted)

$-0.24

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$15M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$54M

Total Liabilities

$25M

Stockholders' Equity

$29M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$72M	$67M	+6.8%
Gross Profit	$43M	$41M	+3.2%
Operating Income	-$19M	-$27M	+31.2%
Net Income	-$17M	-$27M	+39.0%